PharmaTimes18h
Zydus announces USFDA Orphan Drug Designation for Usnoflast in ALS treatment
Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...
Zydus Life rises after USFDA grants orphan drug status to Usnoflast for ALS treatment
Zydus Lifesciences added 1.10% to Rs 987.60 after the company said that the USFDA had granted orphan drug designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic ...
Daily13h
Zydus Lifesciences Dapsone Gel Recalled by USFDA
Zydus Lifesciences Ltd has been implicated in a recall of 23,304 bottles of Dapsone Gel 7.5%, a popular acne treatment distributed under brands such as Nurx and Aczone. The ...
Pharmabiz20h
Zydus’ Usnoflast receives US FDA orphan drug designation to treat amyotrophic lateral sclerosis
Zydus’ Usnoflast receives US FDA orphan drug designation to treat amyotrophic lateral sclerosis: Our Bureau, Mumbai Thursday, January 23, 2025, 12:15 Hrs [IST] Zydus, a leading, ...
USFDA recalls 23,000 bottles of popular face moisturizer: Check brand, reason, and what to do if you have it
The FDA has recalled 23,304 bottles of Dapsone Gel 7.5%, an acne treatment, due to crystallization that can impact dosage and ...
THESE Face Moisturizers Recalled In The US – Full List Of Affected Products
The FDA recalled 23,304 bottles of Dapsone Gel 7.5% due to crystal formation, potentially reducing effectiveness and safety.
ndtvprofit15h
Stocks To Watch Today: Hudco, Waaree Energies, Zydus Lifesciences, Laurus Labs
Zydus Lifesciences: The pharmaceutical company announced the USFDA orphan drug designation to Usnoflast for the treatment of amyotrophic lateral sclerosis. Agro Tech Foods: The CCI approved the ...